Anavex Life Sciences Corp (AVXL)
Stock-Based Compensation
-$11.94M
TTM · Period ending: · USD
AVXL Stock-Based Compensation
Latest reported-$11.94Mperiod ending
Latest reported-$11.94Mperiod ending
AVXL TTM Stock-Based Comp ($0.00 → -$11.94M)
TTM stock-based compensation
High-resolution chart · PNG
AVXL stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| -11,942,000 | |
| 9,152,000 | |
| 10,601,000 | |
| 11,549,000 | |
| 9,841,000 | |
| 8,004,000 | |
| 9,207,000 | |
| 9,438,000 | |
| 10,611,647 | |
| 11,990,647 | |
| 13,308,647 | |
| 16,369,647 | |
| 19,225,398 | |
| 19,348,012 | |
| 19,817,471 | |
| 18,379,242 | |
| 15,488,852 | |
| 13,794,163 | |
| 11,200,860 | |
| 8,231,403 | |
| 5,739,995 | |
| 4,697,199 | |
| 4,551,796 | |
| 4,876,906 | |
| 5,452,836 | |
| 5,435,911 | |
| 5,628,310 | |
| 6,430,873 | |
| 6,685,935 | |
| 7,129,462 | |
| 6,462,006 | |
| 5,517,004 | |
| 5,143,106 | |
| 4,625,091 | |
| 4,368,288 | |
| 4,135,570 | |
| 6,803,176 | |
| 5,871,717 | |
| 5,125,514 | |
| 5,062,267 | |
| 2,645,489 | |
| 2,651,145 | |
| 2,444,637 | |
| 1,633,979 | |
| 893,793 | |
| 669,469 | |
| 653,287 | |
| 637,925 | |
| 1,012,089 | |
| 1,002,500 | |
| 1,002,500 | |
| 1,002,500 | |
| 0 | |
| 98,800 | |
| 178,944 | |
| 302,208 | |
| 559,955 | |
| 620,341 | |
| 1,208,676 | |
| 1,273,162 | |
| 1,161,332 | |
| 1,229,261 | |
| 826,086 | |
| 770,055 | |
| 880,684 | |
| 855,416 | |
| 743,439 | |
| 812,336 | |
| 555,790 | |
| 353,943 | |
| 200,616 | |
| 248,668 | |
| 248,668 | |
| 248,668 | |
| 248,668 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |